Your search
Results 7 resources
-
COVID-19 is a pandemic with a rapidly increasing incidence of infections and deaths. Many pharmacologic therapies are being used or considered for treatment. Given the rapidity of emerging literature, IDSA felt the need to develop living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments...
-
Abstract This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI. This guideline was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). This guideline is intended for use by healthcare professionals who care for...
-
Abstract. Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect bo
-
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
-
Abstract. It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician
Filter by our tag
GUIDELINES
CORE CURRICULUM
-
ORGANISMS
- Bacteria (2)
- Fungi (3)
- Mycobacteria (1)
- Viruses (1)
ORGANISMS
-
BACTERIA
(3)
- C. difficile (1)
- MRSA (1)
- Non-tuberculous Mycobacteria (1)
-
FUNGI
(3)
- Aspergillus (1)
- Candida (1)
- Dimorphic mycoses (1)
-
VIRUSES
(1)
-
COVID-19
(1)
- GUIDELINES (1)
- Treatments (1)
-
COVID-19
(1)